US biotech Cogent Biosciences (Nasdaq: COGT) has seen its share price more than double after its lead drug, bezuclastinib, ...

US contract development and manufacturing organization Avid Bioservices (Nasdaq: CDMO) has appointed Dave Stewart as chief technology and transformation officer, a newly created position that signals ...

US biotech Inovio (Nasdaq: INO) said it plans to offer and sell shares of its common stock in an underwritten public offering ...

Danish CNS specialist Lundbeck today announced results, that showed total revenue grew by +14% CER1 (+13% DKK) to 18,537 ...

Japan’s Otsuka has announced positive findings from a 12-month interim analysis of sibeprenlimab for the treatment of ...

Canadian genetic medicines company enGene Holdings saw its shares rocket as much as 65% to $9.93 in pre-market trading, after ...

Cambridge, USA-based AI-driven biotech Insilico Medicine has announced a research collaboration with Eli Lilly, under which ...

US biopharma Madrigal has announced positive two-year data from the open-label compensated metabolic dysfunction-associated ...

The US regulator is removing boxed warnings for cardiovascular disease, breast cancer and dementia from hormone replacement ...

In today’s rapidly evolving healthcare landscape, the journey from scientific discovery to patient access is more complex ...

Switzerland’s Idorsia has announced the publication of a new analysis from the landmark Phase III PRECISION study.

There is growing recognition that middlemen, like pharmaceutical benefits managers (PBMs) and 340B hospitals, mark up ...